New Prescription Migraine Drugs Aren’t Resonating with Patients—Here’s How Pharma Can Boost Uptake
PM360
JUNE 29, 2022
The migraine therapy market has heated up over the past few years with the emergence of many new acute and preventive medications. And among patients who have tried preventive medications for migraine, 39% said they no longer took them. Doctor-Patient Communication, Self-Advocacy Drive Medication Uptake.
Let's personalize your content